Actual reform measures
affecting drug pricing would likely take years to legislate and implement.
Not exact matches
Changes in the prescription
drug industry
pricing benchmarks may adversely
affect Humana's financial performance.
Other pain points included
drug pricing and how approving more generics may
affect costs (Gottlieb parried that question by noting the FDA doesn't have the authority to negotiate
prices or consider
pricing when approving a
drug) and his alleged softness on opioid
drug makers due the aforementioned financial ties and pro-industry ideology (the nominee noted that he considers opioid addiction and overdoses a public health crisis «on the order of Ebola and Zika»).
The order also calls on the FDA to pass on to the Justice Department any
drug shortages that let market participants «stockpile the
affected drugs or sell them at exorbitant
prices.»
«This deposition and investigation are about better understanding the dramatic
price increases we're seeing for decades old prescription
drugs and how those
prices are
affecting consumers — and we're committed to being thorough in that pursuit.»
He noted, however, that the president and others need to look at all the different influences that
affect prices, not just
drug companies.
Prices for some generic
drugs have increased in recent years, adversely
affecting patients who rely on them.
«Our study confirms some of our thoughts on how
drug prices affect doctors and patients behaviors,» said lead author Tracy Wang, M.D., associate professor of medicine at Duke University School of Medicine and member of DRCI.
Increasingly high
prices for cancer
drugs are
affecting patient care in the U.S. and the American health care system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings.
Hayward could not be specific about the cost of the technique but he says it would not
affect the final
price of a
drug — it is «quite affordable» even for textile companies that are not as flush with cash as the pharma giants.
If a pharmaceutical company loses any of its
drug manufacturing right / permission because of a regulatory effect, then it will definitely
affect the company's profit and hence, the stock
price.